• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Eksterne analyser

Cavotec: Orders strong, miss on sales earnings - ABG

Cavotec

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* Sales EUR 60m vs ABGSCe, EBIT adj. EUR -2.8m vs. ABGSCe 2.5m
* Strong order intake, with several large orders in the end of the quarter
* Market still cautious, cost saving of EUR 3m introduced

Q1 results

Cavotec reported mixed Q1 results with a strong order intake, while missing on top-line and earnings. Order intake came in at EUR 59.7m (vs. ABGSCe 37m, 109% y-o-y), for a R12m book to bill of 1.2. The order beat was expected as they had pre-announced several large orders after we released our Q1 preview. Sales came in at EUR 32.8m (-25% vs. ABGSCe 44m), -15% y-o-y (of which roughly -2% FX). EBIT adj. was EUR -2.8m (vs. ABGSCe EUR 2.5m), for a margin of -8.6% (ABGSCe 5.7%). Industry showed deteriorating sales and margins, with an EBIT margin of 6%% (vs. ABGSCe 11.2%, 13% in Q4'25). Ports & Maritime reported weaker sales and EBIT (sales -26% and adj. EBIT -208% y-o-y). The company is introducing a cost savings program of EUR 3m, with full effect in early 2027.

Estimates and outlook

On numbers alone, '26e-'28e sales is lowered by 7-6%, and EBIT adj. decreases by approx. EUR 2-9m. Q1 was a soft quarter, and while the strong order intake is encouraging, management says the outlook remains uncertain with customer caution persisting.

Valuation
The share has been strong into the numbers, +42% L30D (vs. OMXSALLS +9%), and is currently trading at 48x-21x '26e-'27e P/E on our pre-report estimates vs. the peer median of 20x-19x. The company is hosting a conference call at 10:00 CET.